Rejection Episodes Are Not an Independent Risk Factor for De Novo Donor Specific Antibodies (DSA) after Renal Transplantation

被引：0
|
作者：
Thuraisingham, Raj [1 ,2 ]
Gupta, Arun [3 ]
James, Ajith [2 ]
Hawley, Victoria [1 ]
机构：
[1] Barts & London Queen Marys Sch Med & Dent, London, England
[2] Barts & London NHS Trust, Dept Renal Med & Transplantat, London, England
[3] Barts & London NHS Trust, Clin Transplantat Lab, London, England
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2010年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：416 / 416
页数：1
相关论文
共 50 条
  • [1] CLINICAL RELEVANCE OF DE NOVO DONOR-SPECIFIC HLA ANTIBODIES (DSA) IN RENAL TRANSPLANTATION
    Sommer, Florian
    Kauke, Teresa
    Anthuber, Matthias
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 356 - 356
  • [2] Clinical relevance of de novo donor-specific HLA antibodies (DSA) in renal transplantation
    Sommer, Florian
    Kauke, Teresa
    Rueth, Stefan
    Anthuber, Matthias
    [J]. TRANSPLANTATION, 2016, 100 (07) : S615 - S615
  • [3] The Development of De Novo Donor Specific Antibodies is Associated With Higher Rejection Risk After Heart Transplantation
    Wong, Ka Lam
    Masa, Maria J. Valero
    Taner, Timucin
    Daly, Richard C.
    Kushwaha, Sudhir S.
    Pereira, Naveen
    [J]. CIRCULATION, 2016, 134
  • [4] RISK FACTOR AND CLINICAL COURSE OF ANTIBODY-MEDIATED REJECTION BY DE NOVO DSA AFTER RENAL TRANSPLANTATION
    Okada, Manabu
    Tomosugi, Toshihide
    Futamura, Kenta
    Tsujita, Makoto
    Hiramitsu, Takahisa
    Goto, Norihihiko
    Narumi, Shunji
    Watarai, Yoshihiko
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 118 - 118
  • [5] De novo donor specific anti-HLA antibodies (DSA) following renal transplantation are associated with an increase in rejection episodes in a long-term prospective study
    Fidler, S. J.
    Irish, A.
    Ferrari, P.
    Lim, W.
    Witt, C. S.
    Christiansen, F. T.
    [J]. TISSUE ANTIGENS, 2011, 77 (05): : 461 - 462
  • [6] The Effect of Preformed and De Novo Donor-Specific Antibodies (DSA) in Acute Rejection (AR) After Liver Transplantation (LTX)
    Koch, M.
    Runnebaum, M.
    Goebel, M.
    Thude, H.
    Sterneck, M.
    Marget, M.
    Nashan, B.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [7] PREVALENCE OF DE NOVO DONOR SPECIFIC ANTIBODIES (DSA) IN ORGAN TRANSPLANTATION AFTER SWITCH TO EVEROLIMUS
    Perbos, Emma
    Juinier, Estelle
    Dromer, Claire
    Merville, Pierre
    Billes, Marc-Alain
    Taupin, Jean-Luc
    Neau-Cransac, Martine
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 89 - 89
  • [8] De novo produced donor specific antibodies post renal transplantation: risk factor or innocent bystanders?
    Ntokou, Irma-Sofia A.
    Vittoaki, Angeliki G.
    Apostolaki, Maria D.
    Ioannou, Sophia I.
    Perrea, Despoina N.
    Boletis, John N.
    Iniotaki, Aliki G.
    [J]. TISSUE ANTIGENS, 2010, 75 (05): : 579 - 579
  • [9] De novo donor-specific HLA antibodies in heart transplantation: Do transient de novo DSA confer the same risk as persistent de novo DSA?
    Moayedi, Yasbanoo
    Fan, Chun-Po S.
    Tinckam, Kathryn J.
    Ross, Heather J.
    McCaughan, Jennifer A.
    [J]. CLINICAL TRANSPLANTATION, 2018, 32 (11)
  • [10] DE NOVO HLA DONOR SPECIFIC ANTIBODIES (DSA) AFTER ABO COMPATIBLE LIVER TRANSPLANTATION (LT)
    Del Bello, Arnaud
    Congy, Nicolas
    Kamar, Nassim
    Rostaing, Lionel
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 303 - 303
12345